Cohen Yuval

Avg. Two Year Performance

30% Avg. Purchase Return

14% Compound

No sale track record

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	2%	< 1%	18%	17%	30%
Purchase Success Rate	6 of 13	4 of 13	5 of 13	3 of 13	5 of 13
Average Sale Return	--	--	--	--	--
Sale Success Rate	--	--	--	--	--

Corbus Pharmaceuticals Hold...

Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 77.22K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--